Tag:
New Jersey
Latest Headlines
Latest Headlines
Allergan to enlist new hires in R&D expansion
Allergan has ambitious plans to swell its ranks with the opening of a new R&D facility in the Garden State. The news comes amid a major push at Allergan to expand the use of Botox far beyond fixing facial wrinkles and to develop therapies for a variety of ailments.
Sanofi sharpening budget ax in ongoing R&D restructuring effort
The news last week that Sanofi ( $SNY ) is reconfiguring its U.S. R&D operations in New Jersey and Massachusetts could be a harbinger of deep cuts for its European arena. The U.K.'s Business Weekly
Pfizer's court victory puts NJ hormone suits in question
A New Jersey appellate court may have just negated more than 150 lawsuits over hormone replacement therapy. The panel ruled last week that Pfizer ( $PFE ) can't be sued by two women who claim that HRT
Fast-growing Novo Nordisk plans new hires as it blueprints U.S. HQ
Novo Nordisk is planning to renovate an old Merrill Lynch facility in New Jersey, making it into a new U.S. headquarters campus as it expands with hundreds of corporate and clinical development
Pharma among NJ networks to seek info on employer skill needs
New Jersey is building talent networks around seven industry sectors that are leading the state's economy. Among them: life sciences, advanced manufacturing, and logistics and distribution. Workforce
Sweet deal keeps Bayer in NJ
New Jersey officials, including Governor Chris Christie, have cheered Bayer HealthCare Pharmaceuticals' decision to consolidate operations in that state--a move that comes thanks in part to $35
Bayer to combine East Coast ops in NJ
Bayer HealthCare gave New Jersey a boost with its decision to consolidate East Coast operations there. The move will keep 1,000 jobs in the state and add up to 500 more, according to an announcement
Archimedes starts recruiting for new U.S. headquarters
Flush with investment cash and pushing apps for a new nasal spray treatment for breakthrough cancer pain in the U.S. and Europe, the UK's Archimedes Pharma says the time is ripe to establish a
Merck plans to shutter three NJ R&D facilities
A Merck spokesperson has confirmed to Pharmalot that the company plans to close two of its sites in New Jersey this year, with a third facility in the state being phased out by 2012. Following the
New Jersey AG wants pharma-marketing crackdown
New Jersey is joining the queue of states mulling a harder line on drug marketing. The state's attorney general is asking state agencies to crack down on pharma gifts and free meals given to doctors.
